Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population

Thrombosis Research

Volumn 120, Issue 4, 2007, Pages 567-573

  Bereczky, Zsuzsanna ^a   Balogh, Emilia ^a   Katona, Éva ^a   Pocsai, Zsuzsa ^a   Czuriga, István ^a   Széles, György ^a   Kárpáti, Levente ^a   Ádány, Róza ^a   Édes, István ^a   Muszbek, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Coronary artery disease; Coronary sclerosis; Factor XIII; Factor XIII polymorphism; Fibrinogen; Myocardial infarction

Indexed keywords

BLOOD CLOTTING FACTOR 13A; FIBRINOGEN; LEUCINE; VALINE;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; FIBRIN CLOT; GENE FREQUENCY; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEART INFARCTION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ARTERIOSCLEROSIS; CORONARY ARTERIOSCLEROSIS; EPIDEMIOLOGY, MOLECULAR; FACTOR XIII; FIBRINOGEN; HUNGARY; MUTATION, MISSENSE; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROTEIN SUBUNITS; RISK;

EID: 33947302034     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.12.013     Document Type: Article

References (31)

1. Muszbek L., Yee V., and Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 94 (1999) 271-304
2. Bereczky Z., Katona É., and Muszbek L. Fibrin stabilization (factor XIII), fibrin structure and thrombosis. Pathophysiol Haemost Thromb 33 (2003/2004) 430-437
3. Mikkola H., Syrjälä M., Rasi V., Vahtera E., Peltonen L., and Palotie A. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 84 (1994) 517-525
4. Kohler H.P., Stickland M.H., Ossei-Gerning N., Carter A., Mikkola H., and Grant P. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 79 (1998) 8-13
5. Wartiovaara U., Perola M., Mikkola H., Totterman K., Savolainen V., Penttila A., et al. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 142 (1999) 295-300
6. Franco R.F., Pazin-Filho A., Tavella A.H., Simões M.V., Marin-Neto J.A., and Zago M.A. Factor XIII Val34Leu and the risk of myocardial infarction. Haematologica 85 (2000) 67-71
7. Gemmati D., Serino M., Ongaro A., Tognazzo S., Moratelli S., Resca R., et al. A common mutation in the gene for coagulation factor XIII-A (Val34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol 67 (2001) 183-188
8. Kakko S., Elo T., Tapanainen J.M., Huikuri H.V., and Savolainen M.J. Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest 32 (2002) 643-648
9. Chatterjee T., Schröder V., Windecker S., Meier B., and Kohler H.P. Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease. J Thromb Haemost 1 (2003) 861-863
10. Hanser V.S., Diz-Kucukkaya R., Bilge A.K., Ozben B., Oncul A., Ergen G., and Nalcaci M. The association between factor XIII Val34Leu polymorphism and early myocardial infarction. Circ J 70 (2006) 239-242
11. Canavay I., Henry M., Morange P.E., Tiret L., Poirier O., Ebagosti A., et al. Genetic polymorphisms and coronary artery disease in the South of France. Thromb Haemost 83 (2000) 212-216
12. Corral J., González-Conejero R., Iniesta J.A., Riviera J., Martínez C., and Vicente V. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 85 (2000) 293-297
13. Roldan V., Corral J., Marin F., Rivera J., Pineda J., Gonzalez-Conejero R., et al. Role of factor XIII Val34Leu polymorphism in patients < 45 years of age with acute myocardial infarction. Am J Cardiol 91 (2003) 1242-1245
14. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107 (2003) 1117-1122
15. Aleksic N., Ahn C., Wang Y.W., Juneja H., Folsom A.R., Boerwinkle E., et al. Factor XIIIA Val34Leu polymorphism does not predict risk of coronary artery disease: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 22 (2002) 348-352
16. Butt C., Zheng H., Randell E., Robb D., Parfrey P., and Xie Y.G. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction. Blood 101 (2003) 3037-3041
17. Muszbek L. Deficiency causing mutations and common polymorphisms in the factor XIII-A gene. Thromb Haemost 84 (2000) 524-527
18. Köhler H.P., Mansfield M.W., Clark P.S., and Grant P.J. Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease. Thromb Haemost 82 (1999) 1202-1203
19. Lim B.C.B., Ariens R.A., Carter A.M., Weisel J.W., and Grant P.J. Genetic regulation of fibrin structure and function complex gene-environment interactions may modulate vascular risk. Lancet 361 (2003) 1424-1431
20. Mannila M.N., Eriksson P., Ericsson C.G., Hamsten A., and Silveira A. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentrations, fibrin gel structure and risk of myocardial infarction. Thromb Haemost 95 (2006) 420-427
21. Arnaudova A. 10 health questions about the 10. WHOLIS E82865 (2004), WHO Regional Office for Europe, Copenhagen, Denmark
22. European Communities and World Health Organization. Health status overview for countries of Central and Eastern Europe that are candidates for accession to the European Union (July 2002), WHO Regional Office for Europe, Copenhagen, Denmark. http://www.euro.who.int (http://www.euro.who.int)
23. Shemirani A.H., and Muszbek L. Rapid detection of the factor XIII Val34Leu (163G → T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis. Clin Chem Lab Med 42 (2004) 877-879
24. Muszbek L., Bereczky Z., and Katona É. Blood coagulation factor XIII: involvement in fibrinolysis and thrombosis. In: Arnout J., de Gaetano G., Hoylaerts M., Peerlinck K., Van Geet C., and Verhaeghe R. (Eds). Thrombosis. Fundamental and Clinical Aspects (2003), Leuven University Press, Leuven, Belgium 197-224
25. Kobbervig C., and Williams E. FXIII polymorphisms, fibrin clot structure and thrombotic risk. Biophys Chem 112 (2004) 223-228
26. Kohler H.P., Mansfield M.W., Clark P.S., and Grant P.J. Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease. Thromb Haemost 82 (1999) 1202-1203
27. Warner D., Mansfield M.W., and Grant P.J. Coagulation factor XIII and cardiovascular disease in UK Asien patients undergoing coronary angiography. Thromb Haemost 85 (2001) 408-411
28. Balogh I., Szo{double acute}ke G., Kárpáti L., Wartiovaara U., Katona E., Komaromi I., et al. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familiar thrombophilia. Blood 96 (2000) 2479-2486
29. Wartiovaara U., Mikkola H., Szo{double acute}ke G., Haramura G., Karpati L., Balogh I., et al. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost 84 (2000) 595-600
30. Ariens R.A., Philippou H., Nagaswami C., Weisel J.W., Lane D.A., and Grant P.J. The factor XIII V34L polymporhism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 96 (2000) 988-995
31. Collet J.P., Park D., Lesty C., Soria J., Soria C., Montalesot G., et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed. Dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 20 (2000) 1354-1361